Zobrazeno 1 - 10
of 13
pro vyhledávání: '"ML Dahl-Puustinen"'
Autor:
Christina Alm, ML Dahl-Puustinen, E Thunberg, I. Christenson, J Ostman, I Wikstrom, Leif Bertilsson
Publikováno v:
British journal of clinical pharmacology. 30(3)
The pharmacokinetics of a single oral dose of 1.75 mg glibenclamide were studied in 15 healthy Caucasians including five poor metabolisers of debrisoquine and five poor metabolisers of S-mephenytoin. Plasma glibenclamide concentrations and the urinar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::292991216ff2c9f20c66cae6ed097de3
https://pubmed.ncbi.nlm.nih.gov/2121211
https://pubmed.ncbi.nlm.nih.gov/2121211
Autor:
Dahl-Puustinen ML; Department of Clinical Pharmacology, Huddinge University Hospital, Sweden., Alm C, Bertilsson L, Christenson I, Ostman J, Thunberg E, Wikström I
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 1990 Sep; Vol. 30 (3), pp. 476-80.
Autor:
Andersson T; Research Laboratories, AB Hässle, Mölndal, Sweden., Regårdh CG, Dahl-Puustinen ML, Bertilsson L
Publikováno v:
Therapeutic drug monitoring [Ther Drug Monit] 1990 Jul; Vol. 12 (4), pp. 415-6.
Autor:
Aden-Abdi Y; Department of Clinical Pharmacology, Karolinska Institute, Huddinge University Hospital, Sweden., Villén T, Ericsson O, Gustafsson LL, Dahl-Puustinen ML
Publikováno v:
Bulletin of the World Health Organization [Bull World Health Organ] 1990; Vol. 68 (6), pp. 731-6.
Autor:
Bergman U; Department of Clinical Pharmacology, Karolinska Institutet, Huddinge Hospital, Sweden., Dahl-Puustinen ML
Publikováno v:
European journal of clinical pharmacology [Eur J Clin Pharmacol] 1989; Vol. 36 (6), pp. 621-3.
Autor:
Bertilsson L; Department of Clinical Pharmacology, Karolinska Institute, Huddinge Hospital, Sweden., Dahl-Puustinen ML, Nordin C
Publikováno v:
Psychopharmacology series [Psychopharmacol Ser] 1989; Vol. 7, pp. 52-9.
Autor:
Dahl-Puustinen ML; Department of Clinical Pharmacology, Karolinska Institutet, Huddinge Hospital, Sweden., Aberg-Wistedt A, Bertilsson L
Publikováno v:
Pharmacology & toxicology [Pharmacol Toxicol] 1989 Jul; Vol. 65 (1), pp. 37-9.
Autor:
Dahl-Puustinen ML; Department of Clinical Pharmacology, Karolinska Institute, Huddinge Hospital, Sweden., Lidén A, Alm C, Nordin C, Bertilsson L
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 1989 Jul; Vol. 46 (1), pp. 78-81.
Autor:
Dahl-Puustinen ML; Department of Clinical Pharmacology, Karolinska Institute, Huddinge University Hospital, Sweden., Perry TL Jr, Dumont E, von Bahr C, Nordin C, Bertilsson L
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 1989 Jun; Vol. 45 (6), pp. 650-6.
Autor:
Dahl-Puustinen ML; Department of Physiology, University of Turku, Finland., Corell T, Koch K, Puustinen T
Publikováno v:
Prostaglandins, leukotrienes, and essential fatty acids [Prostaglandins Leukot Essent Fatty Acids] 1988 Feb; Vol. 31 (2), pp. 101-6.